Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.
Narita Y, Ueda M, Uchimura K, Kakizoe Y, Miyasato Y, Mizumoto T, Morinaga J, Hayata M, Nakagawa T, Adachi M, Miyoshi T, Sakai Y, Kadowaki D, Hirata S, Mukoyama M, Kitamura K. Narita Y, et al. Among authors: morinaga j. J Pharmacol Sci. 2016 Feb;130(2):110-6. doi: 10.1016/j.jphs.2016.01.003. Epub 2016 Jan 20. J Pharmacol Sci. 2016. PMID: 26887332 Free article.
In vivo contribution of serine proteases to the proteolytic activation of γENaC in aldosterone-infused rats.
Uchimura K, Kakizoe Y, Onoue T, Hayata M, Morinaga J, Yamazoe R, Ueda M, Mizumoto T, Adachi M, Miyoshi T, Shiraishi N, Sakai Y, Tomita K, Kitamura K. Uchimura K, et al. Among authors: morinaga j. Am J Physiol Renal Physiol. 2012 Oct;303(7):F939-43. doi: 10.1152/ajprenal.00705.2011. Epub 2012 Jul 25. Am J Physiol Renal Physiol. 2012. PMID: 22832922 Free article.
Effect of a serine protease inhibitor on the progression of chronic renal failure.
Hayata M, Kakizoe Y, Uchimura K, Morinaga J, Yamazoe R, Mizumoto T, Onoue T, Ueda M, Shiraishi N, Adachi M, Miyoshi T, Sakai Y, Tomita K, Kitamura K. Hayata M, et al. Among authors: morinaga j. Am J Physiol Renal Physiol. 2012 Oct 15;303(8):F1126-35. doi: 10.1152/ajprenal.00706.2011. Epub 2012 Jul 25. Am J Physiol Renal Physiol. 2012. PMID: 22832926 Free article.
The antifibrotic effect of a serine protease inhibitor in the kidney.
Morinaga J, Kakizoe Y, Miyoshi T, Onoue T, Ueda M, Mizumoto T, Yamazoe R, Uchimura K, Hayata M, Shiraishi N, Adachi M, Sakai Y, Tomita K, Kitamura K. Morinaga J, et al. Am J Physiol Renal Physiol. 2013 Jul 15;305(2):F173-81. doi: 10.1152/ajprenal.00586.2012. Epub 2013 May 22. Am J Physiol Renal Physiol. 2013. PMID: 23698112 Free article.
Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease.
Morinaga J, Kadomatsu T, Miyata K, Endo M, Terada K, Tian Z, Sugizaki T, Tanigawa H, Zhao J, Zhu S, Sato M, Araki K, Iyama K, Tomita K, Mukoyama M, Tomita K, Kitamura K, Oike Y. Morinaga J, et al. Kidney Int. 2016 Feb;89(2):327-41. doi: 10.1016/j.kint.2015.12.021. Epub 2016 Jan 1. Kidney Int. 2016. PMID: 26806834 Free article.
A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity.
Kakizoe Y, Miyasato Y, Onoue T, Nakagawa T, Hayata M, Uchimura K, Morinaga J, Mizumoto T, Adachi M, Miyoshi T, Sakai Y, Tomita K, Mukoyama M, Kitamura K. Kakizoe Y, et al. Among authors: morinaga j. J Pharmacol Sci. 2016 Oct;132(2):145-153. doi: 10.1016/j.jphs.2016.09.005. Epub 2016 Sep 30. J Pharmacol Sci. 2016. PMID: 27773435 Free article.
Angiopoietin-Like Protein 2 Promotes the Progression of Diabetic Kidney Disease.
Ishii T, Furuya F, Takahashi K, Shikata M, Takamura T, Kobayashi H, Miyazaki A, Morinaga J, Terada K, Oike Y, Kanda E, Kitamura K. Ishii T, et al. Among authors: morinaga j. J Clin Endocrinol Metab. 2019 Jan 1;104(1):172-180. doi: 10.1210/jc.2017-02705. J Clin Endocrinol Metab. 2019. PMID: 30137449
76 results